Dr. Dan Atar and Dr. C. Michael Gibson discuss the results of the BETAMI-DANBLOCk Trial of stopping Beta blockers after MI August 30, 2025 Uncategorized BETAMI-DANBLOCK-Hotline-presentation-30-AUG-2025-ESC-Dan-Atar-finalDownload Disclosures: TBD Article Navigation SMuRF-Less but inflamed: Dr Ridker and Dr. C. Michael Gibson discuss the high but modifiable risk of patients without Standard Modifiable Risk Factors who are inflamed. Dr. Kevin Alexander and Dr. C. Michael Gibson discuss: Acoramidis reduces cardiovascular mortality (CVM): results at month 42 from the ATTRibute-CM open-label extension (OLE) study
